Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane and cell wall lipids are essential structural and functional components of the bacterial cell envelope, serving as critical targets for several classes of antibiotics. These lipids, including phosphatidylglycerol, cardiolipin, and specialized precursors like Lipid II and lipopolysaccharide (LPS), maintain membrane fluidity, facilitate cell wall assembly, and provide a barrier against environmental stressors and host immune defenses [1][3]. In Gram-positive bacteria, anionic lipids like phosphatidylglycerol are targeted by lipopeptides such as daptomycin, which cause membrane depolarization and cell death [13]. In Gram-negative bacteria, the outer membrane lipid LPS is the primary target for polymyxins, which disrupt the membrane through a detergent-like mechanism [3][4]. Furthermore, cell wall lipid precursors like Lipid II are vital for peptidoglycan synthesis; their sequestration by glycopeptides or newer agents like teixobactin effectively halts bacterial growth [1][14]. Because these lipid targets are often highly conserved and distinct from eukaryotic membrane compositions, they represent a robust strategy for overcoming multidrug-resistant infections [5][20].
Antibiotics targeting these lipids function through several distinct mechanisms: sequestration of essential cell wall precursors (e.g., Lipid II) to inhibit peptidoglycan synthesis, direct disruption of the cytoplasmic membrane leading to depolarization and ion leakage, or binding to outer membrane components like lipopolysaccharide to increase permeability and cause cell lysis [1][3][14].
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and cell wall lipids.